TY - JOUR
T1 - The therapeutic potential of the calpain family
T2 - new aspects
AU - Saez, Maria E.
AU - Ramirez-Lorca, Reposo
AU - Moron, Francisco J.
AU - Ruiz, Agustin
PY - 2006/10
Y1 - 2006/10
N2 - The calpain family is a group of cysteine proteases unique in their dependency on calcium to attain functionally active forms. Calpains are involved in a wide range of cellular calcium-regulated functions, including signal transduction, cell proliferation and differentiation, and apoptosis. Moreover, altered calpain activity has been observed in several human diseases. Specific calpain inhibitors hold promise for the treatment of neuromuscular and neurodegenerative diseases in which calpains have been shown to be upregulated (e.g. Parkinson's disease and Duchenne muscular dystrophy). Conversely, calpain activators could be a useful approach for those diseases where reduced calpain activity has been observed, such as type 2 diabetes or metabolic syndrome.
AB - The calpain family is a group of cysteine proteases unique in their dependency on calcium to attain functionally active forms. Calpains are involved in a wide range of cellular calcium-regulated functions, including signal transduction, cell proliferation and differentiation, and apoptosis. Moreover, altered calpain activity has been observed in several human diseases. Specific calpain inhibitors hold promise for the treatment of neuromuscular and neurodegenerative diseases in which calpains have been shown to be upregulated (e.g. Parkinson's disease and Duchenne muscular dystrophy). Conversely, calpain activators could be a useful approach for those diseases where reduced calpain activity has been observed, such as type 2 diabetes or metabolic syndrome.
UR - http://www.scopus.com/inward/record.url?scp=33748902211&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748902211&partnerID=8YFLogxK
U2 - 10.1016/j.drudis.2006.08.009
DO - 10.1016/j.drudis.2006.08.009
M3 - Review article
C2 - 16997142
AN - SCOPUS:33748902211
SN - 1359-6446
VL - 11
SP - 917
EP - 923
JO - Drug Discovery Today
JF - Drug Discovery Today
IS - 19-20
ER -